Issue 2/2022
Content (19 Articles)
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example
Christian Jackisch, Federico Manevy, Suzanne Frank, Nicki Roberts, Jason Shafrin
Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence
Yongmei Wang, Fanbo Jing, Haibo Wang
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
Marjanne A. Piena, Sonja Kroep, Claire Simons, Elisabeth Fenwick, Gerard T. Harty, Schiffon L. Wong, Ben A. van Hout
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
Marjanne A. Piena, Sonja Kroep, Claire Simons, Elisabeth Fenwick, Gerard T. Harty, Schiffon L. Wong, Ben A. van Hout
Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan
Kuan-Yuan Chen, Kang-Yun Lee, Albert Qin, Ching-Shan Luo, Yun-Kai Yeh, Jing-Quan Zheng, Ching-Mei Chen, Chan-Yen Tsai, Sheena Lin, Jason Liao, Yi-Wen Huang, Po-Hao Feng
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study
Gouranga Sarkar, Vijay B. Gaikwad, Aradhana Sharma, Swapan K. Halder, Darivemula A. Kumar, Jitendra Anand, Sumit Agrawal, Avinash Kumbhar, Bhushan Kinholkar, Rishabh Mathur, Maulik Doshi, Deepak Bachani, Suyog Mehta
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States
Jan Sieluk, Yan Song, Jonathan Freimark, Min Huang, Amin Haiderali, Richard Berman, Travis Wang, James Signorovitch, Kim Marie Hirshfield
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR
Jeffrey Frankel, David Staskin, Susann Varano, Michael Kennelly, Diane K. Newman, Matt T. Rosenberg, Rachael A. Jankowich, Denise Shortino, Paul N. Mudd Jr, Cynthia J. Girman
Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome
Jennifer Quinn, Alexandros Georgiadis, Hannah B. Lewis, Elaina Jurecki
Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data
Manami Yoshida, Ryosuke Tateishi, Shinzo Hiroi, Masakazu Fujiwara, Yoshitake Kitanishi, Kosuke Iwasaki, Tomomi Takeshima, Ataru Igarashi
The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: Development of an Epidemiology Model Providing Multinational Estimates
Leandra Plappert, Susan Edwards, Assunta Senatore, Angela De Martini
Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
Dominik Lautsch, Robert Boggs, Tongtong Wang, Claudio Gonzalez, Gary Milligan, Swapnil Rajpathak, Seema Malkani, Euan McLeod, James Carroll, Victoria Higgins
Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis
Jill Davis, Rubeen Israni, Keith A. Betts, Fan Mu, Erin E. Cook, Deborah Anzalone, Harold Szerlip, Lei Yin, Gabriel I. Uwaifo, Eric Q. Wu
Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework
Bryony Langford, Alex Diamantopoulos, Toby M. Maher, Yoshikazu Inoue, Klaus B. Rohr, Michael Baldwin
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study
Kurt de Vlam, Adrien Nzeusseu Toukap, Marie-Joëlle Kaiser, Johan Vanhoof, Philip Remans, Marthe Van den Berghe, Silvana Di Romana, Filip Van den Bosch, Rik Lories
Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
Pierre-Dominique Ghislain, Jo Lambert, X. L. Lam Hoai, Tom Hillary, Pierre-Paul Roquet-Gravy, Michel de la Brassinne, Siegfried Segaert
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
Michael Kreuter, Toby M. Maher, Tamera J. Corte, Maria Molina-Molina, Judit Axmann, Frank Gilberg, Klaus-Uwe Kirchgaessler, Vincent Cottin
Correction to: Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study
Shu Hashimoto, Ryoko Sorimachi, Tatsunori Jinnai, Masakazu Ichinose